Huffington Post: Who can get a coronavirus test?
UC expert says screenings will have to be reserved for higher-risk patients
Dr. Carl Fichtenbaum of UC's Division of Infectious Diseases was interviewed by the Huffington Post for a story on who can get tested for coronavirus.
Dr. Carl Fichtenbaum in a lab in the UC Division of Infectious Diseases. Photo credit/Joe Fuqua II/UC Creative + Brand
Dr. Fichtenbaum said until the availability of testing increases, screenings will have to be reserved for higher-risk patients.
Fichtenbaum said that if you have mild symptoms of the virus, the advice is going to be the same whether you have a positive test: “Stay home untll you’re better. Quarantine yourself away from family or roommates or friends. Get rest plenty of liquids. Take some cough syrup or Tylenol for aches and pains.”
Read the full article here.
Dr. Fichtenbaum was also featured in a separate Huffington Post article on how coronavirus tests work. Read that article here.
Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.
Related Stories
The subtle changes in hearing you should never ignore
July 24, 2026
It’s easy to dismiss changes in hearing as minor. But as The Washington Post recently reported, these symptoms could also signal a medical emergency that many people don’t recognize — known as sudden sensorineural hearing loss, a rapid decline in hearing that occurs suddenly or over a few days.
UC experts say proper produce washing is key defense against Cyclospora
July 24, 2026
Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.
What are the options for male birth control?
July 24, 2026
Despite major advances in contraception during the past several decades, responsibility for pregnancy prevention falls largely on women. As recently reported in Endocrinology Advisor, a new generation of male contraceptive candidates is advancing into early- and mid-stage clinical trials.